Ignyta, Inc. (OTCQB:RXDX), an oncology precision medicine biotechnology company, announced today that as of February 5, 2014, Dr. Patrick O’Connor has resigned as Chief Scientific Officer and SVP, Head of Research of the company in order to focus on his health, thereby ending his previously announced medical leave of absence.
Help employers find you! Check out all the jobs and post your resume.
